AQB
AquaBounty Technologies, Inc.
There isn't enough reported data to score AQB yet.
CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
AQB Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
AQB's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
AQB PE Valuation
AQB has no meaningful PE right now: it lost money over the past year.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
AQB Forward outlook
There aren't enough analyst estimates for AQB to show an outlook.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
AQB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$4.51 | +$18.41 |
| Q2 2026 | -$4.58 | +$18.86 |
| Q1 2026 | -$5.13 | +$30.52 |
| Q4 2025 | -$4.77 | +$33.88 |
| Q3 2025 | -$22.92 | -$0.67 |
| Q2 2025 | -$23.44 | -$0.47 |
| Q1 2025 | -$35.65 | -$23.96 |
| Q4 2024 | -$38.65 | -$28.06 |
AQB is still losing money, but far less than before: $4.51 per share over the past year, against $38.65 at its worst in late 2024.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over AQB on earnings quality, reporting a profit while its opponent remains loss making.
AQB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2024 | $47.8K | -93% |
| Q2 2024 | $180.2K | -77% |
| Q1 2024 | $477.3K | +20% |
| Q4 2023 | $553.3K | +23% |
| Q3 2023 | $733.1K | +12% |
| Q2 2023 | $788.4K | -26% |
| Q1 2023 | $397.8K | -59% |
| Q4 2022 | $450.9K | +8% |
CELH has the stronger quarterly revenue trend. Revenue is down 93% for AQB versus up 17% for CELH.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2024 | -4939% | -4110 points |
| Q2 2024 | -27483% | -26666 points |
| Q1 2024 | -2294% | -664 points |
| Q4 2023 | -1503% | -148 points |
| Q3 2023 | -828% | +19 points |
| Q2 2023 | -817% | -296 points |
| Q1 2023 | -1630% | -1100 points |
| Q4 2022 | -1356% | +91 points |
AQB's operating margin was −4939% last quarter, down 4110 points from the same quarter a year ago.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
AQB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$1.4M | +$7M |
| Q3 2024 | -$4.7M | +$21.2M |
| Q2 2024 | -$5.2M | +$24.6M |
| Q1 2024 | -$5.5M | +$23.5M |
| Q4 2023 | -$8.4M | +$17.2M |
| Q3 2023 | -$25.9M | -$4.8M |
| Q2 2023 | -$29.8M | +$880.1K |
| Q1 2023 | -$29.1M | -$18M |
CELH has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with AQB at up 89%.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
AQB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +38.6K shares |
| 1 year | +34% | +1.3M shares |
| 3 years | +45% | +1.6M shares |
| 5 years | +46% | +1.6M shares |
| Available history | +282% | +3.8M shares |
AQB has 5M diluted shares, up 34% from a year ago.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over AQB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
AQB Net Leverage
AQB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
AQB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.1 | Neutral |
| Stochastic | 22.8 | Neutral |
AQB's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
AQB PE vs Consumer Defensive Sector
AQB has no meaningful PE right now: it lost money over the past year.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
AQB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.02 | 17% below |
| 20 week MA | $1.08 | 21% below |
| 50 week MA | $1.00 | 15% below |
| 100 week MA | $0.96 | 11% below |
| 200 week MA | $2.94 | 71% below |
AQB is in a downtrend: it's below all five of its weekly moving averages, and 71% below its 200-week average.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over AQB on trend strength, trading above more of its moving averages.
AQB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $40.2 | $187.8 | +367% |
| 2021 | $187.8 | $44.8 | -76% |
| 2022 | $44.8 | $15.2 | -66% |
| 2023 | $15.2 | $2.85 | -81% |
| 2024 | $2.85 | $0.70 | -75% |
| 2025 | $0.70 | $1.02 | +46% |
| 2026 YTD | $1.02 | $0.85 | -17% |
AQB has the edge over CELH on returns for 2026, with the stronger performance.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.